Skip to content

Aptima® SARS-COV-2 ASSAY CONTROLS, APTIMA, IVD

by Hologic

Ref PRD-07882

Aptima SARS-COV-2 ASSAY CONTROLS, APTIMA, IVD (ASY-16739) is a SARS-CoV-2 nucleic acid IVD (EU IVDR Class B; FDA Class II; FDA product code QQX, Respiratory specimen nucleic acid SARS-CoV-2 test) made by Hologic, registered in EUDAMED on 9 Jul 2026 (Basic UDI-DI 54200455DIAGAPTSARSCOV2CC), cleared under FDA 510(k) K243396 on 13 Feb 2025 and listed in FDA GUDID since 14 Mar 2025 (UDI-DI 15420045517035), active as of 24 Oct 2026.

Active European Union and United States. Also listed in GUDID (US).

CE IVDR 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 24 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

510(k) K243396

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 24 Oct 2026.

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number54200455DIAGAPTSARSCOV2CC Basic UDI-DI 15420045517035UDI-DIDate9 Jul 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number15420045517035 UDI-DI Date14 Mar 2025ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK243396 Date13 Feb 2025DecidedStatusActive

Official records

From the FDA record

Device description
Aptima® SARS-CoV-2 Assay Controls Kit.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 24 Oct 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI 54200455DIAGAPTSARSCOV2CC registered 9 Jul 2026 Active
  • FDA 510(k) K243396 decided 13 Feb 2025 Active
  • FDA GUDID UDI-DI 15420045517035 listed 14 Mar 2025 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K243396
  2. Listed FDA GUDID 15420045517035
  3. Registered EUDAMED 54200455DIAGAPTSARSCOV2CC

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Aptima SARS-CoV-2 Assay Controls Kit EUDAMED
Aptima® GUDID
Generic name
SARS-CoV-2 nucleic acid IVD, control
Device name
Aptima SARS-CoV-2 Assay
Model / Ref / Catalog
PRD-07882 EUDAMED
SARS-COV-2 ASSAY CONTROLS GUDID
APTIMA GUDID
IVD GUDID
ASY-16739 GUDID
Primary DI / UDI-DI
15420045517035
Basic UDI-DI
54200455DIAGAPTSARSCOV2CC
Unit of use DI
05420045517038
510(k) Number
FDA product code
QQX
EMDN code
W0105080899 Controls - inf. immunology - other
GMDN term
SARS-CoV-2 nucleic acid IVD, control
Device class
Class B EUDAMED
Class II GUDID
Regulation number
866.3981
EU registration type
Standard device
EU market of registration
Belgium
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Model / referenceEUDAMED
PRD-07882
GUDID
SARS-COV-2 ASSAY CONTROLS, APTIMA, IVD
Device classEUDAMED
Class B
GUDID
Class II

Device class is stated on each registry's own scale: Class B in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under CONTROLS - INF. IMMUNOLOGY - OTHER.

Other devices from Hologic

See all devices from Hologic →

Properties

  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (20, all answered No)